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MEF2 is an evolutionarily conserved MADS (MCM1, Agamous, Deficiens, and serum response factor) box-type transcription
factor that plays a critical role in vertebrate and Drosophila melanogaster myogenesis. We have addressed the develop-
mental role of the single MEF2-like factor, CeMEF2, in Caenorhabditis elegans. Using expression assays and two mef-2
deletion alleles, we show that CeMEF2 is not required for proper myogenesis or development. Moreover, a putative null
mef-2 allele fails to enhance or suppress the phenotypes of mutants in CeMyoD or CeTwist. Our results suggest that despite
its evolutionary conservation of sequence and DNA binding properties, CeMEF2 has adopted a divergent role in
development in the nematode compared with Drosophila and vertebrates.
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fINTRODUCTION
Several transcription factors are known to regulate
muscle gene expression and are required for proper myogen-
esis. Among these factors is the evolutionarily conserved
myocyte enhancer factor-2 (MEF2) group that appears to be
present in most, if not all, types of vertebrate muscle
tissues. MEF2 was initially purified from muscle cells as a
DNA binding activity that recognized a cis-acting regula-
tory sequence in the promoter of the muscle creatine kinase
(MCK) gene (Gossett et al., 1989). MEF2 was identified
ndependently in vertebrates in a search for genes related to
erum response factor (SRF; originally called RSRF factors)
nd DNA binding studies demonstrated that the RSRFs
ere components of MEF2 DNA binding activity (Pollock
nd Treisman, 1991). Subsequent studies have identified
EF2 sites upstream of numerous muscle-specific genes,
nd there is now a large volume of evidence supporting its
ole as a positively acting transcription factor required for
igh level expression of muscle-specific genes (reviewed in
lack and Olson, 1998). MEF2 has also been shown to be
mportant in the activation of nonmuscle genes in neurons, l
0012-1606/00 $35.00cells, and T cells, helping to explain, at least in part, its
road tissue expression profile in vertebrates (Dodou et al.,
995; Black et al., 1996; Schulz et al., 1996; Swanson et al.,
998; Satyaraj and Storb, 1998; Rao et al., 1998; Naya et al.,
999). Recent reports suggest that MEF2 can also respond to
alcium fluxes to regulate neuron survival (Mao et al., 1999)
nd T cell apoptosis (Youn et al., 1999). For both muscle-
pecific and nonmuscle gene expression, MEF2 often acts
ombinatorially with other transcription factors to result in
ull transcriptional activation of target genes (Molkentin et
l., 1995; Shore and Sharrocks, 1995; Black et al., 1996;
Sartorelli et al., 1997).
MEF2 factors are a subgroup of the larger MADS family of
ranscription factors. The MADS family members all share
highly conserved amino-terminal domain spanning ap-
roximately 60 amino acids known as the MADS box, as
rst noted in the original four members of the family,
CM1, Agamous, Deficiens, and serum response factor
Schwarz-Sommer et al., 1990). The MADS-box domain is
nvolved in DNA binding and dimerization, and these
actors typically act as homodimers or heterodimers (Pol-
ock and Treisman, 1991; Molkentin et al., 1996). The
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432 Dichoso et al.members of the MEF2 group of MADS factors have an
extended region of 29 conserved amino acids, known as the
MEF box, that is a signature domain for this subgroup. The
MEF box is involved in interactions with other proteins and
also influences DNA binding. The preferred MEF2 DNA
binding site (CTA(A/T)4TAG/A) is distinct from the bind-
ing site of other MADS-box family members.
There are four MEF2 genes in vertebrates (mef2a, mef2b,
mef2c, mef2d) that are differentially spliced to generate
multiple MEF2 isoforms (Pollock and Treisman, 1991; Yu
et al., 1992; Breitbart et al., 1993). This isoform complexity,
and presumed redundancy of function, has complicated the
analysis of the roles of MEF2 in the mouse. The clearest
result to date comes from the elimination of mef2c in mice,
which causes embryonic death due to severe cardiovascular
defects (Lin et al., 1998; Bi et al., 1999).
In Drosophila melanogaster there is a single mef2 gene
hat is expressed in all developing muscle tissues and
pecific regions of the brain (Lilly et al., 1994, 1995; Bour et
l., 1995; Taylor et al., 1995). Elimination of DMEF2
ctivity results in the complete absence of all muscle
ifferentiation in Drosophila, providing the cleanest and
ost dramatic evidence for the myogenic role of MEF2
Lilly et al., 1995; Bour et al., 1995). Although muscle
differentiation is blocked, muscle cell precursors are de-
tected in homozygous D-mef2 null mutant animals, dem-
onstrating that muscle fate determination can occur in the
absence of DMEF2 activity.
Promoter analysis of the D-mef2 gene has placed D-mef2
downstream of other transcription factors important for
regulating Drosophila myogenesis. For example, in somatic
muscle D-mef2 is a direct target of activation by the basic
helix-loop-helix (bHLH) factor Twist (Cripps et al., 1998;
Nguyen and Xu, 1998), and Twist has been shown to be
essential for mesoderm formation and myogenesis in Dro-
sophila (Nu¨sslein-Volhard et al., 1984; Simpson, 1983;
Baylies and Bate, 1996). In cardiac muscle, D-mef2 is
activated by the homeodomain factor Tinman (Gajewski et
al., 1997; Nguyen and Xu, 1998), and Tinman is required for
heart formation and differentiation (Azpiazu and Frasch,
1993; Bodmer, 1993).
As part of our studies of myogenesis in the nematode, we
were interested to determine if a MEF2-like factor(s) was
important for muscle formation in Caenorhabditis elegans.
We have identified a single gene in C. elegans encoding a
protein related to MEF2; no additional MEF2-like factors
have been identified in the nearly complete (.99%) genome
sequence (C. elegans Sequencing Consortium, 1998). We
isolated two deletion mutants of mef-2, at least one of
which is likely to be a null allele. Surprisingly, loss of mef-2
activity had little or no effect on C. elegans development
and myogenesis. Double mutants of the putative null mef-2
mutant and either CeMyoD or CeTwist mutants showed no
enhancement of the single-mutant phenotypes. These re-
sults suggest that despite a high level of protein sequence
conservation, MEF2 factors have adopted evolutionarily
divergent roles with respect to myogenesis.
Copyright © 2000 by Academic Press. All rightMATERIALS AND METHODS
Cloning
The C. elegans mef2-like gene was originally identified by PCR
of genomic DNA using degenerate primers to regions of the
conserved MADS and MEF box domains based on vertebrate and
Drosophila sequences. The gene was cloned from a genomic C.
elegans library (kindly provided by C. Link) and the gene and
flanking regions were sequenced (GenBank Accession No.
U36199). The genomic region was mapped to a YAC grid by
Coulson and colleagues and the corresponding cosmids (W10D5
and F27D1) were subsequently sequenced by the Genome Sequenc-
ing Consortium (Accession No. Z79758). A single cDNA clone was
isolated from a mixed-stage C. elegans library (kindly provided by
B. Barstead) and was sequenced in its entirety (Accession No.
U36198). No expressed sequence tags (ESTs) corresponding to this
gene have been identified to date.
Reporter constructs were derived from genomic phage clones.
The largest genomic fragment used was an ;12-kb PstI restriction
fragment covering approximately 9.1 kb of the 59 flanking region of
the gene, exons I and II and part of exon III. This genomic fragment
was fused in-frame to the green fluorescent protein (GFP) reporter
vectors TU63 and pPD95.73 to yield the plasmids pKM3000 and
pKM3001, respectively (Chalfie et al., 1994; A. Fire, G. Seydoux, J.
Ahnn, and S. Q. Xu, personal communication), or to lacZ using the
vector pPD22.11 (Fire et al., 1990). For the TU63 and pPD22.11
constructs an in-frame stop codon within the multiple cloning site
was eliminated. Derivatives of these reporters included a trunca-
tion of the 59 end of the clone to a HindIII restriction site located at
23660 bp relative to the ATG (pMF3) or a HindIII site within intron
I 269 bp downstream of the putative ATG (pMF2, pKM2007).
To inhibit the D1081.2 gene by RNA-mediated interference
(RNAi) we cloned an ;500-bp segment of the locus using the
primers MWK 356 (CGCGAATTCCTTCACTCCATTTCTCGC-
CCCATCAATGGC) and MWK 357 (CGCGGATCCGATGCAAT-
GGCTGCTGATTCGATGAGCTG) into the vector pVZ-1 and
synthesized RNA in vitro from T3 and T7 RNA polymerase
promoters. Double-stranded RNA was prepared and injected into
early adult hermaphrodites as described (Fire et al., 1998).
Strains Used
Two deletion alleles of mef-2 were isolated, KM129 mef-2(gv1)
nd KM130 mef-2(gv2), from a mutant library using the method of
arstead and Moulder as described in Dernburg et al. (1998).
eletion strains were backcrossed to wild-type N2 animals at least
hree times prior to use in subsequent experiments or genetic
rosses. Double-mutant combinations were made between mef-
(gv1) and the CeMyoD null mutant allele hlh-1(cc450), the
eMyoD temperature-sensitive allele hlh-1(cc561), the CeTwist
utant allele hlh-8(nr2061), or the temperature-sensitive
ha-1(e2123ts) allele. The mef-2(gv1) allele was assayed for muscle
efects by direct observation, by antibody staining, and by intro-
ucing the integrated reporters that expressed in either the postem-
ryonic mesoderm (hlh-8::gfp; Harfe et al., 1998a) or the vulval
uscles (egl-15::gfp; Harfe et al., 1998b).
Gel Shifts
The mef2 cDNA clone (pKM1027) was used to synthesize RNA
that was translated in a rabbit reticulocyte lysate (Promega) and
s of reproduction in any form reserved.
oma
433CeMEF2 and Myogenesis in Caenorhabditis elegansused in gel shifts as previously described (Krause et al., 1997).
Double-stranded oligonucleotide probes used were either a canoni-
cal MEF2 binding site (MWK216 CGCTCTAAAAATAACCCT and
its complement) or a mutated MEF2 site (MWK 217 CGCTCTA-
AggcTAACCCT and its complement).
RESULTS
C. elegans Has a Single MEF2-Related Factor
Using a degenerate PCR-based strategy, we identified a
single gene (mef-2) that encodes a protein (CeMEF2) related
to MEF2 from other organisms. The nearly completed
(.99%) genome sequence of C. elegans has failed to reveal
any additional MEF2-like factors (C. elegans Sequencing
FIG. 1. CeMEF2 gene structure and sequence comparison. (A) The
structure shown below. SL1 trans-splicing to the first exon is indi
corresponding to the MADS and MEF domains are underlined by a
comparisons of MEF2 and SRF factors. The MADS and MEF doma
identity shown at right. Sequences include human H-MEF2a, b, c, a
McDermott et al., 1993); Xenopus laevis SL-1 and SL-2 (Chambers
The lower portion of the comparison shows SRF from human (H-S
compared to the gene D1081.2 encoding a second MADS factor in C
D1081.2 is more similar to SRF than to MEF2 within the MADS dConsortium, 1998). Comparison of the sequence from the
Copyright © 2000 by Academic Press. All rightgenomic region of mef-2 with our cDNA sequence informa-
tion reveals a gene structure composed of five exons and
four introns spanning approximately 5.2 kb (Fig. 1A). Struc-
tural features of interest in mef-2 are a potential trans-
spliced leader sequence splice site 55 bp upstream of the
start codon, a large first intron (2376 bp), a relatively long
(811 bp) 39 untranslated region (UTR), and a canonical
poly(A) signal sequence (AATAAA) located upstream of the
poly(A) tail addition site (Krause, 1995). The initial 59-end
sequence of a mef-2 cDNA suggested that the SL1 trans-
spliced leader might be present on the RNA (Krause, 1987).
We have confirmed by reverse transcriptase-polymerase
chain reactions that SL1, but not the alternately spliced
leader SL2, is trans-spliced to a canonical 39 intron splice
acceptor sequence located 55 bp upstream of the putative
/intron structure is shown schematically for mef-2 with the cDNA
by the labeled vertical black bar above the gene. Coding regions
vy black line under the cDNA structure. (B) Amino acid sequence
f several factors are compared with CeMEF2 with the percentage
(Pollock and Treisman, 1991; Yu et al., 1992; Breitbart et al., 1993;
, 1992); D. melanogaster D-MEF2 (Lilly et al., 1994); and CeMEF2.
orman et al., 1988) and Drosophila (D-SRF; Affolter et al., 1994)
ans. Shaded residues are identical in both MEF and SRF. Note that
in and lacks similarity to CeMEF2 within the MEF domain.exon
cated
hea
ins o
nd d
et al.
RF; N
. elegATG.
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434 Dichoso et al.The predicted CeMEF-2 protein is 340 amino acids in
length with a predicted molecular weight of 36.5 kDa. A
canonical 56-residue MADS domain followed immediately
by a 29-residue MEF domain is found at the amino terminus
of the coding region. A comparison of these MADS and MEF
domains to MEF2 proteins identified in other species shows
a remarkable degree of evolutionary conservation of these
domains (Fig. 1B). CeMEF2 is 94% identical to human
MEF2a across these two domains with only five residue
differences, two of which are conservative changes. The
MADS and MEF domains of CeMEF2 are quite distinct
from the amino-terminal domains of the only other known
C. elegans MADS box factor encoded by the gene D1081.2.
Sequence comparisons show that D1081.2 lacks a MEF box
and is more similar to SRF in the MADS domain than to
MEF2 homologs, making the distinction between these two
C. elegans MADS-box factors unambiguous (Fig. 1B).
CeMEF2 Has Conserved Binding Specificity
The MEF2 DNA binding site was initially defined by the
segment of the MCK gene used to purify the binding
activity (Gossett et al., 1989). Subsequent DNA binding
tudies have determined a consensus MEF2 site to be
TA(A/T)4TAR (Pollock and Treisman, 1991). The conser-
ation of CeMEF2 with vertebrate and Drosophila MEF2
factors throughout the MADS and MEF DNA binding
domains suggested that CeMEF2 could bind a typical MEF2
binding site. We tested this hypothesis using rabbit
reticulocyte-translated protein in gel mobility shift assays.
CeMEF2 binds strongly to the canonical MEF2 sequence
and fails to bind when bases in the core of the site are
changed to nonconsensus residues (Fig. 2).
mef-2 Is Expressed Ubiquitously throughout Most
of Development
We have assayed the developmental profile of mef-2
expression using a combination of Northern blot analysis
and reporter gene fusions in transgenic C. elegans. A mef-2
cDNA probe detects one prominent and two minor mRNAs
(1.9, 1.6, and 1.3 kb) by Northern analysis of either total or
poly(A)1 RNA (Fig. 3). These messages are detected at all
tages of development. The longest message (1.9 kb) is
onsistent with the size expected from our single cDNA
lone. Given the long 39 UTR, differences in transcriptional
ermination or poly(A) addition sites within this UTR
ight be responsible for the other two mef-2 mRNA size
lasses (although we have been unable to confirm this with
DNA or EST clones).
We have used gfp and lacZ reporter gene fusions to assay
emporal and spatial patterns of mef-2 promoter activity.
sing a genomic segment extending ;9.3 kb upstream of
he predicted ATG, we observed initial embryonic expres-
ion in neurons and later expression in all tissues. This
xpression pattern begins late in embryogenesis (two-fold
tage) and continues throughout postembryonic develop-
Copyright © 2000 by Academic Press. All rightent (Fig. 4). A similar pattern was observed with reporter
onstructs containing only ;3.6 kb of upstream genomic
equences, although the intensity of expression was re-
uced compared with the longer construct. Truncation of
he 59 end of the reporter genes to a restriction site within
he first intron eliminated expression of the transgenic
eporter genes. We have raised antibodies against a bacteri-
lly expressed CeMEF2 fusion protein. The polyclonal an-
ibodies recognized the fusion protein by Western blot
nalysis, but we have been unable to detect the endogenous
eMEF2 protein by either Western blot or in situ immuno-
ocalization.
mef-2 Is a Nonessential Gene
Using the method of Barstead and Moulder (Dernburg et
al., 1998), we screened a mutagenized population for indi-
vidual animals harboring deletions within the C. elegans
mef-2 gene. The deletion screen was done by PCR using
nested primers located in intron I and the untranslated
region of exon V that bracketed an approximately 2-kb
segment of the gene. Two independent deletion events were
FIG. 2. CeMEF2 binds a consensus MEF2 binding site. In vitro
ranslation products from reaction with (1) or without (2) mef-2
NA were used in gel shift experiments. Two probes were used,
ne with the consensus MEF2 binding site (CTAAAAATA) and the
ther in which core residues of the MEF2 binding site were altered
in lowercase: CTAAggcTA). A single strong band (arrow) is seen
ith mef-2 RNA using the consensus oligonucleotide probe. Use of
arge amounts of CeMEF-2 translation product resulted in two
trongly shifted species, presumably reflecting homodimer and
ligomeric complexes (data not shown).identified in a screen of a library representing 4.8 3 105
s of reproduction in any form reserved.
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435CeMEF2 and Myogenesis in Caenorhabditis elegansmutagenized chromosomes. Animals with Cemef-2 dele-
tions were identified and culled by sib selection through
successively smaller pools until single animals homozy-
gous for the each deletion allele were isolated.
One of the deletions, mef-2(gv1), removes 1376 bp begin-
ning in intron I and extending through intron IV (Fig. 5A).
This deletion is predicted to be a null allele because the
deletion removes most of the MADS and MEF domains that
are required for MEF2 function (Pollock and Treisman,
1991). The second deletion, mef-2(gv2), removes 760 bp
beginning in exon III and ending in exon V. This deletion
leaves the MADS and MEF domains intact but results in a
truncation of the C-terminal 167 residues of the protein and
a frame shift in the coding region after the deletion break
point. The rearrangements in both deletion alleles have
been confirmed by Southern blot analysis of genomic re-
striction fragment patterns (data not shown). Northern blot
analysis of the two deletion alleles reveals that stable, albeit
expectedly smaller, mRNAs can still be detected in these
animals. A prominent mRNA band of 1.2 kb was observed
in mef-2(gv1) and of 1.6 kb in mef-2(gv2) compared with a
ild-type size of 1.9 kb (Fig. 5B).
We have not detected any strong visible phenotype in
nimals homozygous for either mef-2 deletion allele al-
hough mef-2(gv1) animals are slightly short and fat, or
umpy (Dpy), as adults. Both mef-2(gv1) and mef-2(gv2)
omozygous mutant animals develop, move, and reproduce
t rates indistinguishable from those of wild-type animals.
FIG. 3. Northern analysis of mef-2 expression in C. elegans. To
the left is an autoradiograph of a developmental Northern blot of
total RNA (15 mg/lane) isolated from staged populations of animals
as indicated at top. Ethidium bromide staining of the gel prior to
transfer confirmed near-equal loading of RNA in all lanes of the gel.
To the right is a Northern blot of poly(A)1 RNA (1.5 mg per lane)
solated from a mixed-stage population of animals. Three messages
re detected using a full-length mef-2 cDNA probe. A prominent
and of 1.9 kb corresponding in size to a single cDNA clone is
resent throughout development and weaker bands of 1.6 and 1.3
b are also visible.taining with a muscle-specific monoclonal antibody to b
Copyright © 2000 by Academic Press. All rightyosin heavy chain or the filamentous actin binding pro-
ein phalloidin failed to reveal any overt defects in myogen-
sis. We have also assayed specific muscle groups to look
or subtle defects in myogenesis during postembryonic
evelopment corresponding to the period of highest
ef-2::gfp reporter gene expression. Two GFP reporter
enes that are expressed postembryonically provide a sen-
itive assay for mesodermal patterning (hlh-8::gfp) and vul-
al muscle formation (egl-15::gfp) (Harfe et al., 1998a,b). No
efects in reporter gene expression or pattern were observed
n the mef-2(gv1) strain containing either reporter gene. We
ave also tested the ability of a mef-2::gfp reporter construct
o be expressed in the mef-2(gv1) mutant background to
ook for autoregulatory requirements and perhaps reveal a
olecular phenotype for the mutant. Expression of this
eporter is indistinguishable from that observed in a wild-
ype genetic background. It is possible that CeMEF2 is
equired for more subtle aspects of development such as
FIG. 4. Expression pattern of a mef-2::gfp reporter gene. Nearly
biquitous somatic cell expression is shown in this L1 larva
arboring a reporter gene containing ;12 kb of genomic mef-2
equence. The top shows a merged bright-field and GFP image;
elow is the fluorescent image alone.
s of reproduction in any form reserved.
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436 Dichoso et al.neuronal function and animal behavior; we have not tested
directly for these traits.
Cemef-2 Mutants Failed to Enhance Other Muscle
Mutants
Redundancy among myogenic factors acting in concert
could mask the effects of the loss of any one factor. MEF2
has been shown to interact with myogenic bHLH factors
(Molkentin et al., 1995; Molkentin and Olson, 1996) and to
be a direct target of Twist inhibition in other organisms
(Spicer et al., 1996). We have generated strains with double
utant combinations between mef-2(gv1) and predicted
null alleles of hlh-1 (encoding CeMyoD), hlh-8 (encoding
CeTwist), or pha-1 (encoding a bZIP-related transcription
factor) to see if redundancy of these other myogenic factors
and CeMEF2 might be revealed. We assayed all double
mutants for obvious enhancement of single-mutant pheno-
types with respect to myogenesis. Loss of CeMyoD activity
results in morphological defects during embryogenesis and
loss of muscle contractility (Chen et al., 1992). Homozy-
gous hlh-1 mutant animals hatch out as malformed larvae
that are unable to move and that usually die during the L1
stage. We tested both the null hlh-1(cc450) and the
emperature-sensitive hlh-1(cc561) alleles for phenotypic
hanges when placed in combination with the putative null
llele mef-2(gv1). Double-homozygous mef-2(gv1); hlh-
(cc450) and mef-2(gv1); hlh-1(cc561) animals were indis-
inguishable from hlh-1 mutant homozygotes alone (Fig. 6).
FIG. 5. mef-2 deletion alleles and RNA expression. (A) A sche-
matic of the mef-2 gene with exons shown as boxes and the
MADS/MEF box regions shaded in black. Heavy black lines below
the gene indicate the genomic DNA missing in the gv1 and gv2
eletion alleles. (B) Northern blot analysis of total RNA isolated
rom mixed populations of wild-type (N2) and mef-2 mutant alleles
gv1 and gv2).oss of CeTwist activity affects only a subset of mesoderm,
Copyright © 2000 by Academic Press. All rightausing a loss of some of the enteric and egg-laying muscles
n the hermaphrodite (Corsi et al., 2000). Double-
omozygous mef-2(gv-1); hlh-8(nr2061) animals are indis-
inguishable from homozygous hlh-8(nr2061) mutants with
o obvious defects in muscle groups other than those
ffected by CeTwist mutations alone (data not shown).
inally, we tested double mutants of mef-2(gv1) and the
ene pha-1, which encodes a transcription factor required
or complete differentiation of the pharynx, a muscular
rgan used to pump food into the animal (Schnabel and
chnabel, 1990; Granato et al., 1994). Double-homozygous
ef-2(gv1); pha-1(e2123ts) were phenotypically identical to
ha-1(e2123ts) alone when raised at the restrictive tem-
erature based on pharyngeal morphology using Nomarski
ptics and staining with the monoclonal antibody 3NB12,
hich recognizes the pharyngeal muscles (Okamato and
hompson, 1985).
Although no other MEF2-like sequences have been iden-
ified in the genome, a related SRF-like MADS box factor is
ncoded by the D1081.2 locus. In vertebrates, SRFs are
mportant for proper regulation of muscle-specific and non-
uscle genes (reviewed in Treisman 1990, 1994). To test
he possibility that D1081.2 provided redundant function in
nimals lacking CeMEF2, we inhibited D1081.2 function
y RNAi (Fire et al., 1998) in wild-type and mef-2(gv1)
utant animals. D1081.2(RNAi) in a wild-type background
aused a progressive larval uncoordinated (Unc) phenotype.
lthough many progeny of D1081.2(RNAi)-injected her-
FIG. 6. mef-2 mutations fail to enhance or suppress the pheno-
type in animals deficient for CeMyoD activity. The hlh-1(cc450)
null (A) and hlh-1(cc561) temperature-sensitive (C) CeMyoD L1
mutant phenotypes are compared with hlh-1; mef-2(gv1) double-
homozygous mutants (B and D, respectively). Double-mutant ani-
mals are indistinguishable from the single hlh-1 mutant animals;
most of the animals progress to the L1 stage, arrest development,
and die.
s of reproduction in any form reserved.
437CeMEF2 and Myogenesis in Caenorhabditis elegansmaphrodites became Unc, this phenotype was not fully
penetrant. Because the onset of the Unc phenotype was
progressive and variable it is difficult to quantitate precisely
the fraction of affected progeny. The mef-2(gv1);
D1081.2(RNAi) phenotype was qualitatively similar to that
of D1081.2(RNAi) in a wild-type background. In order to
observe the quantitative similarity of RNAi in affected
wild-type versus mef-2(gv1) animals, we scored day 2 prog-
eny (maximal RNAi effect) from individual adult animals
injected with D1081.2 dsRNA for the Unc phenotype. Of
injected animals giving rise to Unc progeny, an average of
81% of the progeny were affected (n 5 393, range 45–96%)
in the wild-type background and an average of 68% (n 5
431, range 8–97%) were affected in the mef-2(gv1) back-
ground. We considered these percentages to be similar given
the difficulty of scoring affected progeny accurately.
DISCUSSION
At the amino acid level, there is an extremely high
evolutionary conservation of MEF2 factors throughout the
amino-terminal MADS and MEF domains, implying con-
servation of function across these regions. Indeed, we find
that CeMEF2 strongly binds a canonical MEF2 site and fails
to bind DNA in which core residues in the binding site have
been altered. In Drosophila, D-MEF2 is essential for all
types of myogenesis (Lilly et al., 1995; Bour et al., 1995;
Ranganayakulu et al., 1995) and in mammals at least two of
the MEF2 isoforms are essential for viability (Lin et al.,
1998; Bi et al., 1999; E. Olson, personal communication).
We have shown here that despite the conservation in
protein sequence and DNA binding activity, CeMEF2 is not
essential for C. elegans myogenesis and development.
One explanation for the lack of muscle defects associated
with loss of CeMEF2 is redundancy of function via another
MEF2 isoform or related factor. Although the essentially
complete genomic sequence has failed to reveal additional
MEF2-like factors, C. elegans does have one additional
MADS box transcription factor (D1081.2) that is most
closely related to serum response factors. SRF is generally
considered to be a transcriptional mediator of extracellular
signals (e.g., growth factors) and is known to be important
in many vertebrate tissues (reviewed in Treisman, 1990,
1994). In addition to regulating c-fos in many cell types, SRF
has also been demonstrated to be important for cell-type-
specific transcription in muscle cells. For example, SRF
binding sites have been identified upstream of numerous
smooth muscle-specific promoters (Browning et al., 1998),
and recently SRF has been shown to be required for coro-
nary smooth muscle cell development (Landerholm et al.,
1999). SRF null mice are embryonic lethal with severe
gastrulation defects and fail to form mesoderm, demon-
strating a general requirement for SRF during development
(Arsenian et al., 1998). In Drosophila, the only known
SRF-like factor is encoded by the pruned gene, which is
required for terminal outgrowth and branching of the tra-
Copyright © 2000 by Academic Press. All rightcheal system (Affolter et al., 1994; Guillemin et al., 1996).
Our RNAi results with the SRF-like factor encoded by the
D1081.2 locus in C. elegans suggest that this factor is
required postembryonically for proper locomotion of the
animal. The RNAi results do not distinguish between
defects associated with nerve versus muscle function so we
cannot assume that D1081.2 is required for proper muscle
function. We have, however, tested directly for redundancy
between D1081.2 and mef-2 using D1081.2 RNAi in a
mef-2(gv1) mutant background. Our results provide no
evidence of redundant function for these two factors.
C. elegans appears to have evolved a developmental
program of myogenesis that is independent of MEF2 func-
tions. In Drosophila, all myogenesis is dependent on MEF2,
and mutant studies in the mouse suggest an essential role
for MEF2 in at least some aspects of muscle development.
Apparently C. elegans myogenesis has diverged during
evolution. Several other unique aspects of C. elegans myo-
genesis have been described previously. In vertebrates,
heterodimers of members of the bHLH transcription factor
families MyoD and E are required for muscle cell fate
determination and differentiation. The activity of these
heterodimeric complexes is negatively regulated by HLH Id
factors that are capable of competing for binding to E factors
but fail to bind DNA as heterodimeric complexes (reviewed
in Weintraub et al., 1991). In contrast, CeMyoD is not
required for muscle cell fate identity in C. elegans and is
not required for expression of most muscle-specific genes
(Chen et al., 1992). Moreover, the C. elegans
E/Daughterless-related factor CeE/DA is not coexpressed
with CeMyoD during embryogenesis in differentiating stri-
ated muscles and fails to heterodimerize efficiently with
CeMyoD in vitro (Krause et al., 1997; Zhang et al., 1999).
No Id-like gene has been identified among the 24 known
HLH genes present in the C. elegans genomic sequence.
Although CeMEF2, CeMyoD, and CeE/DA all display a
high level of evolutionary conservation across the core
functional domains, the precise roles in nematode muscle
development are apparently divergent from those in other
systems. These divergent roles presumably reflect func-
tions and protein–protein interactions that are mediated by
the substantial regions of these proteins that are not con-
served.
Why are the MADS and MEF domains of CeMEF2 so
highly related to those of other species if the factor itself is
not essential in C. elegans? Conservation across the MADS
and MEF domains reflects DNA binding and dimerization
constraints, aspects of CeMEF2 function that our present
studies confirm to be conserved. These properties must be
evolutionarily selected for by conferring some advantages
to C. elegans, although these advantages are not evident
under laboratory culture conditions. Like SRF, MEF2 fac-
tors function as part of a complex of factors present at the
promoters of target genes. MEF2 has been reported to
interact directly with both tissue-restricted bHLH factors
(Molkentin et al., 1995; reviewed in Yun and Wold, 1996)
and more general transcription factors such as p300 (Sar-
s of reproduction in any form reserved.
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438 Dichoso et al.torelli et al., 1997) and SP1 (Grayson et al., 1998). Perhaps a
major function of MADS box factors is to stabilize or
maintain activated transcription complexes to ensure full-
level expression of target genes in response to extracellular
cues. During evolution, one can imagine that a common
ancestral MADS box factor duplicated, allowing MEF2 and
SRF-related factors to evolve more specialized functions.
During this specialization, C. elegans myogenesis may have
become more dependent on the SRF-related factor, whereas
Drosophila myogenesis became dependent on the MEF2-
elated factor. In vertebrates, both MEF2 and SRF are
mportant myogenic factors, reflecting perhaps a middle
volutionary road relative to Drosophila and C. elegans.
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